ALOX5 inhibition protects against dopaminergic neurons undergoing ferroptosis

Subramaniam, 2013, Mitochondrial dysfunction and oxidative stress in Parkinson's disease[J], Prog. Neurobiol., 106–107, 17, 10.1016/j.pneurobio.2013.04.004 Lin, 2021, Neuroprotective effects of San-Jia-Fu-Mai decoction: studies on the in vitro and in vivo Models of Parkinson's Disease[J]. World, J. Tradit. Chin. Med., 7, 192 Rascol, 2011, Milestones in Parkinson's disease therapeutics[J]. Movement disorders: official journal of the Movement Disorder, Society, 26 Henchcliffe, 2005, Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors[J], Expert Rev. Neurother., 5, 10.1586/14737175.5.6.811 Kalia, 2015, Parkinson's disease[J], Lancet, 386, 896, 10.1016/S0140-6736(14)61393-3 Lew, 2007, Overview of Parkinson's disease[J], Pharmacotherapy, 27 Jiang, 2021, Ferroptosis: mechanisms, biology and role in disease[J], Nat. Rev. Mol. Cell Biol., 22, 10.1038/s41580-020-00324-8 Seibt, 2019, Role of GPX4 in ferroptosis and its pharmacological implication[J], Free Radic. Biol. Med., 133, 10.1016/j.freeradbiomed.2018.09.014 Stockwell, 2017, Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease[J], Cell, 171, 10.1016/j.cell.2017.09.021 Mahoney-Sánchez, 2021, Ferroptosis and its potential role in the physiopathology of Parkinson's Disease[J], Prog. Neurobiol., 196, 10.1016/j.pneurobio.2020.101890 Wei, 2018, Oxidative stress in Parkinson's disease: a systematic review and meta-analysis[J], Front. Mol. Neurosci., 11, 236, 10.3389/fnmol.2018.00236 David, 2022, Dysregulation of iron homeostasis in the central nervous system and the role of ferroptosis in neurodegenerative disorders[J], Antioxid. Redox Signal., 37 Han, 2020, Ferroptosis and its potential role in human diseases[J], Front. Pharmacol., 11, 239, 10.3389/fphar.2020.00239 Paul, 2018, Cysteine metabolism in neuronal redox homeostasis[J], Trends Pharmacol. Sci., 39, 10.1016/j.tips.2018.02.007 Finkelstein, 2017, The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease[J]. Acta Neuropathol, Communications, 5, 53 Lang, 2018, Disease modification in parkinson's disease: current approaches, challenges, and future considerations[J], Mov. Disord.: Off. J. Mov. Disord. Soc., 33, 10.1002/mds.27360 Sun, 2019, Emerging roles of 5-lipoxygenase phosphorylation in inflammation and cell death[J], Oxid. Med. Cell. Longev., 2019, 2749173, 10.1155/2019/2749173 Gaschler, 2017, Lipid peroxidation in cell death[J], Biochem. Biophys. Res. Commun., 482, 10.1016/j.bbrc.2016.10.086 Pergola, 2015, Progesterone rapidly down-regulates the biosynthesis of 5-lipoxygenase products in human primary monocytes[J], Pharmacol. Res., 94, 42, 10.1016/j.phrs.2015.01.007 Chou, 2014, Gene-environment interaction models to unmask susceptibility mechanisms in Parkinson's disease[J], J. Vis. Exp.: JoVE, 83 Kang, 2013, Protection of dopaminergic neurons by 5-lipoxygenase inhibitor[J], Neuropharmacology, 73, 10.1016/j.neuropharm.2013.06.014 Zou, 2019, Standardized Xin-Ke-Shu tablets improves the disturbances of lipid, energy, and amino acid metabolism in a rabbit model of atherosclerosis[J], World J. Tradit. Chin. Med., 5, 71, 10.4103/wjtcm.wjtcm_13_19 Li, 2022, Protective effects of ginsenoside CK against oxidative stress-induced neuronal damage, assessed with 1H NMR-based metabolomics[J]. Acta Materia, Medica Liang, 2022, Paeoniflorin rescued MK-801-induced schizophrenia-like behaviors in mice via oxidative stress pathway[J], Front. Nutr., 9, 10.3389/fnut.2022.870032 Sun, 2023, Sophora alopecuroides alleviates neuroinflammation and oxidative damage of Parkinson's disease in vitro and in vivo[J], Am. J. Chin. Med., 51, 10.1142/S0192415X23500167 Wang, 2020, (+)-Clausenamide protects against drug-induced liver injury by inhibiting hepatocyte ferroptosis[J], Cell death Dis., 11, 781, 10.1038/s41419-020-02961-5 Chu, 2014, Recent advances in the study of (-)clausenamide: chemistry, biological activities and mechanism of action[J], Acta Pharm. Sin. B., 4, 10.1016/j.apsb.2014.10.004 Karuppagounder, 2018, N-acetylcysteine targets 5 lipoxygenase-derived, toxic lipids and can synergize with prostaglandin E(2) to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in mice[J], Ann. Neurol., 84, 10.1002/ana.25356 Hu, 2010, Protective effect of (-)clausenamide against Abeta-induced neurotoxicity in differentiated PC12 cells[J], Neurosci. Lett., 483, 78, 10.1016/j.neulet.2010.07.067 Ning, 2012, -)Clausenamide facilitates synaptic transmission at hippocampal Schaffer collateral-CA1 synapses[J], Eur. J. Pharmacol., 682 Xu, 2005, (-)-Clausenamide potentiates synaptic transmission in the dentate gyrus of rats[J], Chirality, 17, 10.1002/chir.20150 Hu, 2012, Activation of ERK1/2-CREB pathway during potentiating synaptic transmission of (-)clausenamide in rat dentate gyrus[J], J. Asian Nat. Prod. Res., 14, 10.1080/10286020.2011.650885 Jiang, 2020, Tianma Gouteng granules decreases the susceptibility of Parkinson's disease by inhibiting ALOX15-mediated lipid peroxidation[J], J. Ethnopharmacol., 256, 10.1016/j.jep.2020.112824 Herman, 2013, Neuroimaging as a window into gait disturbances and freezing of gait in patients with Parkinson's disease[J], Curr. Neurol. Neurosci. Rep., 13, 411, 10.1007/s11910-013-0411-y Gaven, 2014, Primary culture of mouse dopaminergic neurons[J], J. Vis. Exp.: JoVE, e51751, 1 de Farias, 2016, Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson's disease and its progression: Disease and staging biomarkers and new drug targets[J], Neurosci. Lett., 617, 66, 10.1016/j.neulet.2016.02.011 Stockwell, 2020, The chemistry and biology of ferroptosis[J], Cell Chem. Biol., 27, 10.1016/j.chembiol.2020.03.013 Proneth, 2019, Ferroptosis and necroinflammation, a yet poorly explored link[J], Cell death Differ., 26, 14, 10.1038/s41418-018-0173-9 Gerstmeier, 2016, 5-Lipoxygenase-activating protein rescues activity of 5-lipoxygenase mutations that delay nuclear membrane association and disrupt product formation[J], FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol., 30, 10.1096/fj.201500210R Enyedi, 2016, The cell nucleus serves as a mechanotransducer of tissue damage-induced inflammation[J], Cell, 165, 10.1016/j.cell.2016.04.016 Ma, 2021, PKC-β/Alox5 axis activation promotes Bcr-Abl-independent TKI-resistance in chronic myeloid leukemia[J], J. Cell. Physiol., 236, 10.1002/jcp.30301 Do Van, 2016, Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC[J], Neurobiol. Dis., 94, 10.1016/j.nbd.2016.05.011 Weiland, 2019, Ferroptosis and Its Role in Diverse Brain Diseases[J], Mol. Neurobiol., 56, 10.1007/s12035-018-1403-3 Hirschhorn, 2019, The development of the concept of ferroptosis[J], Free Radic. Biol. Med., 133, 10.1016/j.freeradbiomed.2018.09.043 Zheng, 2020, The metabolic underpinnings of ferroptosis[J], Cell Metab., 32, 10.1016/j.cmet.2020.10.011 Friedmann Angeli, 2014, Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice[J], Nat. Cell Biol., 16, 10.1038/ncb3064 Dixon, 2012, Ferroptosis: an iron-dependent form of nonapoptotic cell death[J], Cell, 149, 10.1016/j.cell.2012.03.042 Angelopoulou, 2021, Neuroprotective potential of cinnamon and its metabolites in Parkinson's disease: Mechanistic insights, limitations, and novel therapeutic opportunities[J], J. Biochem. Mol. Toxicol., 35, 10.1002/jbt.22720 Bae, 2018, The neuroprotective effects of cinnamic aldehyde in an MPTP mouse model of Parkinson's disease[J], Int. J. Mol. Sci., 19, 551, 10.3390/ijms19020551 Mythri, 2012, Curcumin: a potential neuroprotective agent in Parkinson's disease[J], Curr. Pharm. Des., 18, 10.2174/138161212798918995 Luz, 2014, 5-lipoxygenase-dependent recruitment of neutrophils and macrophages by eotaxin-stimulated murine eosinophils[J], Mediat. Inflamm., 2014, 10.1155/2014/102160 Rodríguez, 2016, Pharmacological inhibition of eicosanoids and platelet-activating factor signaling impairs zymosan-induced release of IL-23 by dendritic cells[J], Biochem. Pharmacol., 102, 78, 10.1016/j.bcp.2015.12.001 Dufrusine, 2019, Iron-dependent trafficking of 5-lipoxygenase and impact on human macrophage activation[J], Front. Immunol., 10, 1347, 10.3389/fimmu.2019.01347 Kang, 2020, Oxidative stress and diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications[J], Redox Biol., 37, 10.1016/j.redox.2020.101799 Mochly-Rosen, 2012, Protein kinase C, an elusive therapeutic target?[J], Nat. Rev. Drug Discov., 11, 10.1038/nrd3871 Zhang, 2022, PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis[J], Nat. Cell Biol., 24, 88, 10.1038/s41556-021-00818-3